Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if a drug, called methylprednisolone, is safe and
effective in people with Hantavirus infection. Individuals 2 years of age or older are
invited to participate in this study if their doctor suspects or knows they have Hantavirus
infection. Volunteers will either be given methylprednisolone or placebo (contains no
medication) through a needle inserted in a vein for 3 days. During the first 7 days of
hospitalization procedures may include blood tests, physical exams, chest x-rays, and urine
tests. During study visits on days 14, 28, 84 and 180 after diagnosis, the doctors will ask
about health, examine the body, take a chest X-ray, collect blood for safety testing and for
measuring antibodies, and do breathing tests on volunteers. Participants will be involved in
the study for about 6 months.
Phase:
Phase 2
Details
Lead Sponsor:
University of New Mexico
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)